SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-004718
Filing Date
2019-03-13
Accepted
2019-03-13 07:38:07
Documents
13
Period of Report
2019-03-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20190312_8k.htm 8-K 24612
2 EXHIBIT 99.1 ex_137388.htm EX-99.1 40684
3 EXHIBIT 99.2 ex_137389.htm EX-99.2 5526
4 a09.jpg GRAPHIC 149009
5 a08.jpg GRAPHIC 130389
6 a07.jpg GRAPHIC 136880
7 a06.jpg GRAPHIC 79217
8 a05.jpg GRAPHIC 105201
9 a04.jpg GRAPHIC 131295
10 a03.jpg GRAPHIC 50883
11 a02.jpg GRAPHIC 271581
12 a01.jpg GRAPHIC 46712
13 logo.jpg GRAPHIC 4579
  Complete submission text file 0001437749-19-004718.txt   1595803
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 19677090
SIC: 2834 Pharmaceutical Preparations